- **Root cause of vulnerability**: The Hospira Symbiq Infusion System has an exposed dangerous method or function that, with remote access and elevated privileges, allows it to be remotely directed to perform unanticipated operations.
- **Weaknesses/vulnerabilities present**: The vulnerability is classified as an exposed dangerous method or function (CWE-749). The system's design allows for remote control via network access when combined with elevated privileges. The device also has default credentials for access on some ports that can be exploited
- **Impact of exploitation**: Successful exploitation allows an attacker to remotely control the device, potentially impacting prescribed therapy and patient safety.
- **Attack vectors**: The attack vector is remote network access.
- **Required attacker capabilities/position**: An attacker requires network access to the device and elevated privileges. The complexity of the attack is rated as medium skill.